Efficacy of Administration of an Angiotensin Converting Enzyme Inhibitor for Two Years on Autonomic and Peripheral Neuropathy in Patients with Diabetes Mellitus

Table 3

Changes in indices of diabetic peripheral neuropathy during the study in patients who received quinapril (group A) and in those who did not (group B).

	Group A ()			Group B ()
	Baseline	End of treatment	p; (versus baseline)	Baseline	End of treatment	p; (versus baseline)
Michigan Neuropathy Screening Instrument			NS			NS
Vibration perception threshold			NS			NS